Alertas Bibliograficas – Pediatría
ciencia-2
Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
Morgan SA, Hassan-Smith ZK, Doig CL, Sherlock M, Stewart PM, Lavery GG.
J Endocrinol. 2016 Jun;229(3):277-86. Epub 2016 Apr 5.
doi: https://10.1530/JOE-16-0011.
pedia-1
Advances in treatment of glucocorticoid-induced osteoporosis.
Hsu E, Nanes M.
Curr Opin Endocrinol Diabetes Obes. 2017 Dec;24(6):411-417
doi: https://doi.org/10.1097/MED.0000000000000368
pedia-2
Osteogenesis imperfecta: diagnosis and treatment.
Palomo T, Vilaça T, Lazaretti-Castro M.
Curr Opin Endocrinol Diabetes Obes. 2017 Dec;24(6):381-388
DOI:https://doi.org/10.1097/MED.0000000000000367
endo-1
The 2017 Bethesda System for Reporting Thyroid Cytopathology.
Cibas ES, Ali SZ.
Thyroid. 2017 Nov;27(11):1341-1346.
doi: http://dx.doi.org/10.1089/thy.2017.0500
PMID: 29091573
endo-2
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH5 et al.
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903.
doi: http://dx.doi.org/10.1210/jc.2017-01658
DIABETES-2
The 2017 Clinical Practice Guideline for High Blood Pressure
Paul K. Whelton, Robert M. Carey
JAMA. Published online November 20, 2017
doi: http://dx.doi.org/10.1001/jama.2017.18209
DIABETES-1
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
Conceptt Collaborative Group
The Lancet: Published on line 15 September 2017
doi: http://dx.doi.org/10.1016/S0140-6736(17)32400-5
DIABETES-3
Review of basal-plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus.
D. Raccah, D. Huet, A. Dib, F. Joseph, B. Landers, J. Escalada,H. Schmitt
Diabetic Medicine, 2017 Sept: 1193–1204
DOI: http://dx.doi.org/10.1111/dme.13390
DIABETES-4
Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?
S. K. Paul and R. R. Holman
Diabetic Medicine, 2017 Sept;34;9:1284-1290
DOI: http://dx.doi.org/10.1111/dme.13376
DIABETES-5
Older people with Type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies.
Hambling CE, Seidu SI, Davies MJ, Khunti K
Diabet Med. 2017 Sep;34(9):1219-1227.
http://dx.doi.org/10.1111/dme.13380.
Epub 2017 Jun 5.